[1]
|
Bray, F., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 10.
|
[3]
|
Moloney, J.N. and Cotter, T.G. (2018) ROS Signalling in the Biology of Cancer. Seminars in Cell and Developmental Biology, 80, 50-64. https://doi.org/10.1016/j.semcdb.2017.05.023
|
[4]
|
Lu, S.C. (2009) Regulation of Glutathione Synthesis. Molecular Aspects of Medicine, 30, 42-59.
https://doi.org/10.1016/j.mam.2008.05.005
|
[5]
|
Kearns, P.R., Pieters, R., Rottier, M.M.A., et al. (2001) Raised Blast Glutathione Levels Are Associated with an Increased Risk of Relapse in Childhood Acute Lymphocytic Leukemia. Blood: The Journal of the American Society of Hematology, 97, 393-398. https://doi.org/10.1182/blood.V97.2.393
|
[6]
|
Ankita, B., et al. (2018) Glutathione Metabolism in Cancer Progression and Treatment Resistance. Journal of Cell Biology, 217, 2291-2298. https://doi.org/10.1083/jcb.201804161
|
[7]
|
Assi, M. (2017) The Differential Role of Reactive Oxygen Species in Early and Late Stages of Cancer. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 313, R646-R653.
https://doi.org/10.1152/ajpregu.00247.2017
|
[8]
|
Singh, S., Khan, A.R. and Gupta, A.K. (2012) Role of Glutathione in Cancer Pathophysiology and Therapeutic Interventions. Journal of Experimental Therapeutics and Oncology, 9, 303-316.
|
[9]
|
Yeh, C.C., Hou, M.F., Wu, S.H., et al. (2010) A Study of Glutathione Status in the Blood and Tissues of Patients with Breast Cancer. Cell Biochemistry & Function, 24, 555-559. https://doi.org/10.1002/cbf.1275
|
[10]
|
Almadori, G., Bussu, F., Galli, J., et al. (2010) Salivary Glutathione and Uric Acid Levels in Patients with Head and Neck Squamous Cell Carcinoma. Head & Neck, 29, 648-654. https://doi.org/10.1002/hed.20579
|
[11]
|
Grubben, M., van Den Braak, C.C.M., Nagengast, F.M., et al. (2006) Low Colonic Glutathione Detoxification Capacity in Patients at Risk for Colon Cancer. European Journal of Clinical Investigation, 36, 188-192.
https://doi.org/10.1111/j.1365-2362.2006.01618.x
|
[12]
|
Huang, C.S., Chang, L.S. anderson, M.E., et al. (1993) Catalytic and Regulatory Properties of the Heavy Subunit of Rat Kidney Gamma-Glutamylcysteine Synthetase. Journal of Biological Chemistry, 268, 19675-19680.
https://doi.org/10.1016/S0021-9258(19)36569-X
|
[13]
|
Huang, C.S. anderson, M.E. and Meister, A. (1993) Amino Acid Sequence and Function of the Light Subunit of Rat Kidney Gamma-Glutamylcysteine Synthetase. Journal of Biological Chemistry, 268, 20578-20583.
https://doi.org/10.1016/S0021-9258(20)80764-9
|
[14]
|
Franklin, C.C., Backos, D.S., Mohar, I., et al. (2009) Structure, Function, and Post-Translational Regulation of the Catalytic and Modifier Subunits of Glutamate Cysteine Ligase. Molecular Aspects of Medicine, 30, 86-98.
https://doi.org/10.1016/j.mam.2008.08.009
|
[15]
|
Gupta, A., Srivastava, S., Prasad, R., et al. (2010) Oxidative Stress in Non-Small Cell Lung Cancer Patients after Chemotherapy: Association with Treatment Response. Respirology, 15, 349-356.
https://doi.org/10.1111/j.1440-1843.2009.01703.x
|
[16]
|
Jia, X., Guan, B., Liao, J., et al. (2019) Down-Regulation of GCLC Is Involved in Microcystin-LR-Induced Malignant Transformation of Human Liver Cells. Toxicology, 421, 49-58. https://doi.org/10.1016/j.tox.2019.03.010
|
[17]
|
Sun, J., Zhou, C., Ma, Q., et al. (2019) High GCLC Level in Tumor Tissues Is Associated with Poor Prognosis of Hepatocellular Carcinoma after Curative Resection. Journal of Cancer, 10, 3333. https://doi.org/10.7150/jca.29769
|
[18]
|
Kim, A.D., Zhang, R., Han, X., et al. (2015) Involvement of Glutathione and Glutathione Metabolizing Enzymes in Human Colorectal Cancer Cell Lines and Tissues. Molecular Medicine Reports, 12, 4314-4319.
https://doi.org/10.3892/mmr.2015.3902
|
[19]
|
Mi Je, E.M., An, C.H., Yoo, N.J., et al. (2012) Mutational and Expressional Analyses of NRF2 and KEAP1 in Sarcomas. Tumori Journal, 98, 510-515. https://doi.org/10.1177/030089161209800417
|
[20]
|
Mougiakakos, D., Okita, R. ando, T., et al. (2012) High Expression of GCLC Is Associated with Malignant Melanoma of Low Oxidative Phenotype and Predicts a Better Prognosis. Journal of Molecular Medicine, 90, 935-944.
https://doi.org/10.1007/s00109-012-0857-4
|
[21]
|
Järvelä, S., Nordfors, K., Jansson, M., et al. (2008) Decreased Expression of Antioxidant Enzymes Is Associated with Aggressive Features in Ependymomas. Journal of Neuro-Oncology, 90, 283-291.
https://doi.org/10.1007/s11060-008-9658-6
|
[22]
|
Soini, Y., Karihtala, P., Mäntyniemi, A., et al. (2004) Glutamate-L-Cysteine Ligase in Breast Carcinomas. Histopathology, 44, 129-135. https://doi.org/10.1111/j.1365-2559.2004.01768.x
|
[23]
|
McConnachie, L.A., Mohar, I., Hudson, F.N., et al. (2007) Glutamate Cysteine Ligase Modifier Subunit Deficiency and Gender as Determinants of Acetaminophen-Induced Hepatotoxicity in Mice. Toxicological Sciences, 99, 628-636.
https://doi.org/10.1093/toxsci/kfm165
|
[24]
|
Harris, I.S., Treloar, A.E., Inoue, S., et al. (2015) Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression. Cancer Cell, 27, 211-222. https://doi.org/10.1016/j.ccell.2014.11.019
|
[25]
|
Inoue, Y., Tomisawa, M., Yamazaki, H., et al. (2003) The Modifier Subunit of Glutamate Cysteine Ligase (GCLM) Is a Molecular Target for Amelioration of Cisplatin Resistance in Lung Cancer. International Journal of Oncology, 23, 1333-1339. https://doi.org/10.3892/ijo.23.5.1333
|
[26]
|
Syu, J.P., Chi, J.T. and Kung, H.N. (2016) Nrf2 Is the Key to Chemotherapy Resistance in MCF7 Breast Cancer Cells under Hypoxia. Oncotarget, 7, 14659-14672. https://doi.org/10.18632/oncotarget.7406
|
[27]
|
Albrethsen, J., et al. (2011) Gel-Based Proteomics of Liver Cancer Progression in Rat. Biochimica et Biophysica Acta, 1814, 1367-1376. https://doi.org/10.1016/j.bbapap.2011.05.018
|
[28]
|
Zheng, Z.G., Xu, H., Suo, S.S., et al. (2016) The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer. Scientific Reports, 6, Article No. 26093.
https://doi.org/10.1038/srep26093
|
[29]
|
Koto, K.S., Lescault, P., Brard, L., et al. (2011) Antitumor Activity of Nifurtimox Is Enhanced with Tetrathiomolybdate in Medulloblastoma. International Journal of Oncology, 38, 1329-1341. https://doi.org/10.3892/ijo.2011.971
|
[30]
|
Li, M., Zhang, Z., Yuan, J., et al. (2014) Altered Glutamate Cysteine Ligase Expression and Activity in Renal Cell Carcinoma. Biomedical Reports, 2, 831-834. https://doi.org/10.3892/br.2014.359
|
[31]
|
李墨农. 谷氨酰半胱氨酸连接酶在膀胱癌中表达的研究[D]: [博士学位论文]. 济南: 山东大学, 2014.
|
[32]
|
Cheng, M.L., Lu, Y.F., Chen, H., et al. (2015) Liver Expression of Nrf2-Related Genes in Different Liver Diseases. Hepatobiliary & Pancreatic Diseases International, 14, 485-491. https://doi.org/10.1016/S1499-3872(15)60425-8
|
[33]
|
Cortes-Wanstreet, M.M., et al. (2009) Overexpression of Glutamate-Cysteine Ligase Protects Human COV434 Granulosa Tumour Cells against Oxidative and Gamma-Radiation-Induced Cell Death. Mutagenesis, 24, 211-224.
https://doi.org/10.1093/mutage/gen073
|